Phibro Animal Health Corporation (NASDAQ:PAHC) to Issue $0.12 Quarterly Dividend

Key Points

• Phibro Animal Health Corporation announced a quarterly dividend of $0.12 per share, with an annualized dividend of $0.48 and a yield of 1.71%, supported by a dividend payout ratio of 23.9%.
• Shares of PAHC fell 3.1% to $28.01, with a market cap of $1.14 billion and 12-month trading range between $16.16 and $31.80.
• Analysts have mixed ratings on the stock, with a consensus “Hold” rating and price targets ranging from $24.00 to $35.00, following several upgrades from major banks.

Phibro Animal Health Corporation (NASDAQ:PAHC - Get Free Report) declared a quarterly dividend on Tuesday, July 29th, RTT News reports. Shareholders of record on Wednesday, September 3rd will be paid a dividend of 0.12 per share on Wednesday, September 24th. This represents a c) dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date is Wednesday, September 3rd.

Phibro Animal Health has a payout ratio of 23.9% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Phibro Animal Health to earn $2.10 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 22.9%.

Phibro Animal Health Trading Down 1.5%

Shares of PAHC stock traded down $0.39 during mid-day trading on Friday, hitting $26.11. 356,504 shares of the company's stock were exchanged, compared to its average volume of 303,453. The stock has a market cap of $1.06 billion, a price-to-earnings ratio of 33.47, a PEG ratio of 0.44 and a beta of 0.80. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67. Phibro Animal Health has a fifty-two week low of $16.16 and a fifty-two week high of $31.80. The stock has a 50-day simple moving average of $26.70 and a two-hundred day simple moving average of $23.29.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, beating the consensus estimate of $0.52 by $0.11. The company had revenue of $347.80 million during the quarter, compared to analysts' expectations of $352.41 million. Phibro Animal Health had a return on equity of 30.51% and a net margin of 2.68%. Equities analysts expect that Phibro Animal Health will post 1.95 EPS for the current fiscal year.

Institutional Trading of Phibro Animal Health

Several large investors have recently bought and sold shares of PAHC. Sterling Capital Management LLC grew its holdings in Phibro Animal Health by 2.4% during the 4th quarter. Sterling Capital Management LLC now owns 18,762 shares of the company's stock valued at $394,000 after purchasing an additional 448 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Phibro Animal Health by 4.7% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,164 shares of the company's stock valued at $260,000 after acquiring an additional 546 shares in the last quarter. State of Alaska Department of Revenue lifted its stake in shares of Phibro Animal Health by 7.6% in the second quarter. State of Alaska Department of Revenue now owns 12,129 shares of the company's stock worth $309,000 after acquiring an additional 859 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its holdings in Phibro Animal Health by 10.0% in the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 11,530 shares of the company's stock valued at $294,000 after purchasing an additional 1,044 shares during the last quarter. Finally, Financial Management Professionals Inc. acquired a new stake in Phibro Animal Health during the 2nd quarter valued at approximately $32,000. Institutional investors and hedge funds own 99.34% of the company's stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.